Ani Pharmaceuticals Inc (ANIP)
Gross Profit Growth
21.30%
Quarterly · Period ending:
ANIP Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported21.30%period ending
Latest reported21.30%period ending
ANIP Quarterly Gross Profit YoY % (-100.00% → 21.30%)
Year-over-year change
High-resolution chart · PNG
ANIP gross profit growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Gross Profit Growth |
|---|---|
| 21.3007% | |
| -0.9058% | |
| 115.388% | |
| 31.1235% | |
| 70.2173% | |
| 40.5696% | |
| 40.9796% | |
| 1.8262% | |
| 8.1858% | |
| 27.7874% | |
| 35.1052% | |
| 64.4079% | |
| 92.5858% | |
| 128.6897% | |
| 114.2207% | |
| 84.1978% | |
| 46.5585% | |
| -12.5376% | |
| -17.3667% | |
| -15.8638% | |
| -5.2709% | |
| 23.4752% | |
| 8.422% | |
| -9.561% | |
| -28.2763% | |
| -26.7072% | |
| -18.4325% | |
| 3.5244% | |
| 26.2429% | |
| 47.9721% | |
| 37.813% | |
| 29.5799% | |
| 29.7479% | |
| 27.4084% | |
| 26.0153% | |
| 23.9294% | |
| 20.9805% | |
| 18.0636% | |
| 46.9403% | |
| 30.7803% | |
| 19.3405% | |
| 6.8357% | |
| -16.5227% | |
| 16.655% | |
| 261.479% | |
| 93.8867% | |
| 121.2538% | |
| 175.1242% | |
| 11.7691% | |
| 465.7599% | |
| 965.2224% | |
| 335.4674% | |
| 3,625.8687% | |
| -2,085.0526% | |
| -1,509.0535% | |
| -1,309.8378% | |
| 34.2913% | |
| 100% | |
| -54.994% | |
| 256.0889% | |
| -97.4999% | |
| -86.5568% | |
| 389.2394% | |
| -100% | |
| 3,231.7852% | |
| -70.5251% | |
| -87.2379% | |
| 345.1776% | |
| 50.0713% | |
| 996.4989% | |
| 87.7286% | |
| -62.7495% | |
| -9.9016% | |
| -97.6549% | |
| -68.7915% | |
| -60.3734% | |
| -40.2355% | |
| 14,376.8714% | |
| 61.0957% | |
| 284.3561% | |
| 195.2854% | |
| 76.8511% | |
| 709.3849% | |
| 816.3183% | |
| 291.9765% | |
| 198.4275% | |
| -57.6283% | |
| -91.3228% | |
| -103.0254% | |
| -97.3613% | |
| 202.3965% | |
| -44.9145% | |
| -100% |